Cholesteryl ester transfer protein, low density lipoprotein particle size and intima media thickness in patients with coronary heart disease. 2011

Katerina Tosheska, and Danica Labudovic, and Silvana Jovanova, and Branko Jaglikovski, and Sonja Alabakovska
Department of Medical and Experimental Biochemistry, University "Ss Cyril and Methodius", Skopje, Republic of Macedonia. tosheskatrajkovska@gmail.com

Cholesteryl ester transfer protein (CETP) plays a key role in reverse cholesterol transport and high density lipoprotein (HDL) metabolism. Predominance of small, dense LDL particles is associated with an increased risk of atherosclerosis and coronary heart disease (CHD).The aim of the study was to determine the potential relationship between the CETP concentration and low density lipoprotein (LDL) particle size and their association with intima media thickness (IMT) in patients with CHD. Lipid parameters, CETP concentration and LDL particle size were determined in 100 healthy subjects (control group) and in 100 patients with CHD, aged 43 to 77 years. Plasma CETP concentrations were measured by an enzyme-linked immuno-sorbent assay with two different monoclonal antibodies. LDL subclasses were separated by nondenaturing polyacrilamide 3-31% gradient gel electrophoresis. CETP concentration was higher in patients compared to controls (2.02 ± 0.75 mg/ml vs. 1.74 ± 0.63 mg/ml, p<0.01). Mean LDL particle size (nm) was significantly smaller in patients than in controls (24.5 ± 1.1 vs. 26.1 ± 0.9; p<0.001). There was no relation between LDL particle size and CETP concentration (r=-0.1807, p=0.072). Age, diastolic blood pressure, CETP concentration and LDL particle size were independent factors for determing IMT by multiple linear regression analysis. They accounted for 35.2 % of the observed variability in IMT. CETP is not an independent contributor of LDL particle size. CETP might play a role in determining lipoprotein distributions, but did not seem to be the sole factor in the formation of small LDL particles.

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride

Related Publications

Katerina Tosheska, and Danica Labudovic, and Silvana Jovanova, and Branko Jaglikovski, and Sonja Alabakovska
July 2010, European journal of clinical investigation,
Katerina Tosheska, and Danica Labudovic, and Silvana Jovanova, and Branko Jaglikovski, and Sonja Alabakovska
May 1992, Biochimica et biophysica acta,
Katerina Tosheska, and Danica Labudovic, and Silvana Jovanova, and Branko Jaglikovski, and Sonja Alabakovska
May 2007, Metabolism: clinical and experimental,
Katerina Tosheska, and Danica Labudovic, and Silvana Jovanova, and Branko Jaglikovski, and Sonja Alabakovska
April 2002, Atherosclerosis,
Katerina Tosheska, and Danica Labudovic, and Silvana Jovanova, and Branko Jaglikovski, and Sonja Alabakovska
August 2001, Current opinion in lipidology,
Katerina Tosheska, and Danica Labudovic, and Silvana Jovanova, and Branko Jaglikovski, and Sonja Alabakovska
December 2006, Metabolism: clinical and experimental,
Katerina Tosheska, and Danica Labudovic, and Silvana Jovanova, and Branko Jaglikovski, and Sonja Alabakovska
February 1997, The Journal of biological chemistry,
Katerina Tosheska, and Danica Labudovic, and Silvana Jovanova, and Branko Jaglikovski, and Sonja Alabakovska
August 2006, Current opinion in lipidology,
Katerina Tosheska, and Danica Labudovic, and Silvana Jovanova, and Branko Jaglikovski, and Sonja Alabakovska
November 2000, Clinica chimica acta; international journal of clinical chemistry,
Katerina Tosheska, and Danica Labudovic, and Silvana Jovanova, and Branko Jaglikovski, and Sonja Alabakovska
September 2009, The American journal of cardiology,
Copied contents to your clipboard!